TG THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
TG THERAPEUTICS, INC. (TGTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 56.25 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-02-27
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-12-31 was 8.81K shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-09-30 was 4.17K shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-06-30 was 46.60K shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-03-31 was 66.59K shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 56.25K shares, a 25.00% decline from fiscal 2024.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 75.00K shares, a 61.04% decline from fiscal 2023.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 192.50K shares, a 17.06% increase from fiscal 2022.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 164.44K shares, a 2670.73% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 56.25K shares 10-K · filed 2026-02-27 | ||||
| 2024-12-31 | 75.00K shares 10-K · filed 2026-02-27 | ||||
| 2023-12-31 | 192.50K shares 10-K · filed 2026-02-27 | ||||
| 2022-12-31 | 164.44K shares 10-K · filed 2025-03-03 | ||||
| 2021-12-31 | 5.93K shares 10-K · filed 2024-02-29 | ||||
| 2020-12-31 | 118.75K shares 10-K · filed 2023-03-01 | ||||
| 2019-12-31 | 8.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 12.98K shares derived: sum of 2 quarters · filed 2022-03-01 | 59.58K shares derived: sum of 3 quarters · filed 2022-03-01 | 126.17K shares 10-K · filed 2022-03-01 | |
| 2019-09-30 | 4.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 50.77K shares derived: sum of 2 quarters · filed 2019-11-12 | 117.36K shares 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | 46.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 113.19K shares 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | 66.59K shares 10-Q · filed 2019-05-10 | ||||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 0.00 shares 10-Q · filed 2018-11-09 | |||
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-09 | ||||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2015-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2015-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2015-05-11 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares 10-K · filed 2015-03-16 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-14 | 0.00 shares 10-Q · filed 2014-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-16 | |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | 0.00 shares 10-Q · filed 2014-07-24 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-16 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 313.00 shares 10-K · filed 2015-03-16 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-14 | 313.00 shares 10-Q · filed 2013-11-14 | 5.26K shares derived: sum of 4 quarters · filed 2014-03-07 | |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 313.00 shares 10-Q · filed 2013-08-09 | 5.26K shares derived: sum of 3 quarters · filed 2014-03-07 | 5.26K shares derived: sum of 4 quarters · filed 2014-03-07 | |
| 2013-03-31 | 313.00 shares 10-Q · filed 2013-05-14 | 5.26K shares derived: sum of 2 quarters · filed 2014-03-07 | 5.26K shares derived: sum of 3 quarters · filed 2014-03-07 | ||
| 2012-12-31 | 4.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | 4.95K shares derived: sum of 2 quarters · filed 2014-03-07 | 2.48K shares 10-K · filed 2014-03-07 | -2.48K shares 10-K · filed 2013-03-21 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -2.48K shares 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | -2.48K shares 10-Q/A · filed 2012-09-07 | ||||
| 2011-12-31 | -364.00 shares 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |